Contact Phone
93 363 89 20

Dr. Josep Malvehy Guilera

Medical director of the Dermatological Diagnósis Clinic. COMB 28569

Dr. Josep Malvehy is a world leader in research in the diagnosis and treatment of melanoma and skin cancer with extensive experience in this field. He is the director of the skin cancer (melanoma) program at the Hospital Clínic of Barcelona and a consultant at Memorial Sloan Kettering Cancer Center of New York (USA).

He is a consultant to different European governments and the United States (NIH) for new technologies and treatment in skin cancer. He is currently the leader of the ISIC digital technology group).

Dr. Josep Malvehy is a professor at the American Academy of Dermatology and the European Academy of Dermatology and Venereology, CILAD, and a member of the Spanish Academy of Dermatology and Venereology.

He is a member and Spanish representative of the Board of the EADO (European Association of Dermato Oncology) and a member of the Melanoma Group of the EORTC and ESMO, the main European oncology organizations.

He is a founding member of the International Dermoscopy Society, the Confocal Working Group and the International Society of teledermatology. He is a full member of the European Academy of Doctors.

Professor at the American Academy of Dermatology.

Professor at the European Academy of Dermatology and Venereology.

Director and professor in more than 50 national and international courses in his specialty with more than 4,000 students to date.

Graduate in Medicine and Surgery from the University of Barcelona.

Doctor of Medicine and specialist in darmatology.

Associate professor at the University of Barcelona.

More than 25 years of experience.

Director of the Melanoma Unit of the Hospital Clínic of Barcelona.

Diagnosis and treatment of skin cancer, confocal microscopy, digital dermoscopy and biophotonics techniques.

Specialist in melanocytic lesions and in the diagnosis, treatment and genetic research of melanoma.

Dermatological surgery.

Skin cancer

Melanoma, Carcinoma and pigmentary lesions

Epiluminescence microscopy

InVivo Confocal Microscopy

Vectra360 3D photodynamic images

Author of more than 350 scientific publications in the most prestigious journals in the world on skin cancer and dermatological diagnosis.

Editor of 4 diagnostic books and author of more than 50 chapters in books in this field.

Director of 7 world congresses on melanoma and skin cancer and director of the scientific program of more than 20 national and international congresses.

Author of more than 100 national and international scientific conferences.

Scientific director and principal investigator of more than 20 projects in skin cancer and non-invasive diagnosis, biomedicine, biophotonics and other fields.

Director of more than 50 national and international skin cancer courses with more than 4,000 students.

Management team and Spanish representative of the European Association of Dermato-Oncology (EADO).

Management team and co-founder of the International Dermoscopy Society.

Management team and co-founder of the International Confocal Working Group.

Management team and co-founder of the International Society of Teledermatology.

Member of the melanoma group of the ESMO (European Society of medical Oncology).

Member of the melanoma group of the EORTC (European Organization of Research and treatment of cancer).

Member of the European Academy of Doctors.

Professor of the American Academy of Dermatology.

Professor of the European Academy of dermatology and venreology.

Academic of the AEDV (Spanish Academy of Dermatology and Venereology).

Sentinel lymph node biopsy versus observation in thick melanoma: A multicenter propensity score matching study.

Boada A, Tejera-Vaquerizo A, Ribero S, Puig S, Moreno-Ramírez D, Descalzo-Gallego MA, Fierro MT, Quaglino P, Carrera C, Malvehy J, Vidal-Sicart S, Bennássar A, Rull R, Alos L, Requena C, Bolumar I, Traves V, Pla Á, Fernández-Figueras MT, Ferrándiz C, Pascual I, Manzano JL, Sánchez-Lucas M, Giménez-Xavier P, Ferrandiz L, Nagore E.

Int J Cancer. 2017 Sep 27. doi: 10.1002/ijc.31078. [Epub ahead of print]

Seven Non-melanoma Features to Rule Out Facial Melanoma.

Tschandl P, Gambardella A, Boespflug A, Deinlein T, de Giorgi V, Kittler H, Lallas A, Malvehy J, Moscarella E, Puig S, Scalvenzi M, Thomas L, Zalaudek I, Alfano R, Argenziano G.

Acta Derm Venereol. 2017 Nov 15;97(10):1219-1224. doi:10.2340/00015555-2759.

Tel. contacto
93 363 89 20

DIAGNOSIS DERMATOLOGICA SL como responsable del tratamiento tratará tus datos con la finalidad de dar de gestionar tu reserva de cita a través de nuestra web. Le informa que podría utilizar la aplicación de WhatsApp como medio de comunicación con sus clientes que implicaría una transferencia internacional de datos la cual se realiza con plenas garantías de acuerdo a la Decisión Adecuación relativa al Marco de Privacidad de datos UE-EE.UU del 10 de julio de 2023. Puedes acceder, rectificar y suprimir tus datos, así como ejercer otros derechos consultando la información adicional y detallada sobre protección de datos en nuestra Política de Privacidad

DIAGNOSIS DERMATOLOGICA SL como responsable del tratamiento tratará tus datos con la finalidad de dar respuesta a tu consulta o petición. Puedes acceder, rectificar y suprimir tus datos, así como ejercer otros derechos consultando la información adicional y detallada sobre protección de datos en nuestra Política de Privacidad

Suscripción Boletín

DIAGNOSIS DERMATOLOGICA SL como responsable del tratamiento tratará tus datos con la finalidad de remitirte nuestra newsletter con novedades comerciales sobre nuestros servicios. Puedes acceder, rectificar y suprimir tus datos, así como ejercer otros derechos consultando la información adicional y detallada sobre protección de datos en nuestra Política de Privacidad

DIAGNOSIS DERMATOLOGICA SL, as the data controller, will process your data in order to manage your appointment reservation through our website. It informs you that you could use the WhatsApp application as a means of communication with your clients, which would involve an international transfer of data which is carried out with full guarantees in accordance with the Adequacy Decision relating to the EU-US Data Privacy Framework of 10 July 2023. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Privacy Policy

DIAGNOSIS DERMATOLOGICA SL, as the data controller, will process your data in order to respond to your query or request. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Privacy Policy

Newsletter Subscription

DIAGNOSIS DERMATOLOGICA SL, as the data controller, will process your data in order to send you our newsletter with commercial news about our services. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Privacy Policy

Course registration